1.93BMarket Cap
11.95P/E TTM
ADMA Biologics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of ADMA Biologics Inc is 6.40, ranking 151 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 11.95, which is 1022.51% below the recent high of 134.13 and 5388.98% above the recent low of -632.00.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.